The Food and Drug Administration’s expert panel also expressed openness to eventually greenlighting boosters for all adult recipients of both the Pfizer-BioNTech and Moderna vaccines — a crucial Biden Administration goal.
. As a result, said Sharon Alroy-Preis, director of public health services at Israel’s Ministry of Health, “there is no question in my mind that the break of the curve” — the country’s recent Delta wave is now in sharp retreat — “was due to the booster dose.”
Given the early indications of waning Moderna efficacy and the evidence from Israel about the impact of Pfizer boosters, the panel ultimately decided to “harmonize” its recommendations for the two mRNA vaccines.“From a pragmatic point of view ... I support this EUA [emergency use authorization] because we’ve already approved it for Pfizer and I don’t see how we can possibly not approve it for Moderna and not have most U.S. folks be completely confused,” said Dr.
The FDA’s expert panel had earlier seemed unified in its opposition to the Biden Administration’s push for boosters for all, and many of those objections remained. But several panel members signaled that they would consider recommending boosters for younger and less vulnerable adults if new data warranted it.
“Is it possible that boosters in the right context could help us get to herd immunity? That’s intriguing,” Dr. Ofer Levy, Director of the Precision Vaccines Program at Boston Children's Hospital, added. He also mentioned “long COVID in children,” saying the current literature was “muddled,” but that additional information could tip the scales in favor of a broader booster rollout.
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
Independent FDA panel votes to authorize Moderna booster for seniors and high-risk AmericansBREAKING: An independent FDA advisory panel voted unanimously to authorize Moderna Covid-19 vaccine boosters for Americans 65 and older, anyone 18 and older with underlying conditions and those frequently exposed to the virus.
Lire la suite »
FDA panel endorses lower-dose Moderna COVID shot for boosterU.S. health advisers said Thursday that some Americans who received Moderna’s COVID-19 vaccine should get a half-dose booster to bolster protection against the virus. The panel of advisers to the Food and Drug Administration voted unanimously to recommend a booster shot for seniors, adults with other health problems, jobs or living situations that put them at increased risk for COVID-19.
Lire la suite »
FDA panel debates lower-dose Moderna COVID shots for boosterU.S. health advisers are debating if millions of Americans who received Moderna vaccinations should get a booster shot -- this time, using half the original dose. Already millions who got their initial Pfizer shots at least six months ago are getting a booster of that brand.
Lire la suite »
FDA advisory group recommends Moderna booster for emergency useJUST IN: FDA advisory panel votes to recommend Moderna booster shots for emergency use authorization for certain at-risk groups.
Lire la suite »